Company news
MaxCyte, Inc. news in 2021
MaxCyte, Inc.'s news releases, calls and decks from 2021, newest first.
MaxCyte Reports Third Quarter Financial Results
November 9, 2021
MaxCyte Signs Strategic Platform License with Nkarta, Inc. to Advance Natural Killer Cell Therapy Programs
October 27, 2021
MaxCyte to Report Third Quarter 2021 Financial Results on November 10, 2021
October 24, 2021
MaxCyte Set to Join Russell 2000® Index
September 16, 2021
MaxCyte Reports Second Quarter and Half-Year 2021 Financial Results Provides Preliminary 2021 Revenue Projections
September 12, 2021
MaxCyte Signs Clinical and Commercial License with Sana Biotechnology
August 8, 2021
Financial information in the Form S-1 registration statement and Change to Board of Directors
July 12, 2021
MaxCyte Announces Public Filing of Registration Statement with SEC for a Proposed Nasdaq Dual Listing
July 12, 2021